BioStock interview with our CMO Kirsten HartingDate: 2024-01-11
Last fall, we welcomed Kirsten Harting to Alzinova as our Chief Medical Officer. With a wealth of expertise in the medical field, Kirsten is an important addition to the team in propelling us forward in our Alzheimer's clinical trials
Recently, BioStock caught up with Kirsten to explore her first impressions of Alzinova and learn more on how she plans to use her experience for shaping our path forward. Read the interview with Kirsten below!